
Amy Swift MD
Addiction
Medical Director, Addiction Psychiatry Program Director, Addiction Psychiatry Fellowship
Join to view full profile
10 Nathan D Perlman PlBernstein Building 6th FlNew York, NY 10003
Phone+1 212-240-2466
Dr. Swift is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Amy Swift is a New York-based Psychiatry specialist. With a subspecialty in Addiction, her education includes a Psychiatry residency and a fellowship in Addiction Psychiatry at Icahn School of Medicine at Mount Sinai (Beth Israel), where she also served as Chief Resident. Two prominent publications, in the Journal of Psychopharmacology and Psychiatry Research respectively, demonstrate her particular interest in the intersection of cannabis use and psychosis.
Education & Training
Icahn School of Medicine at Mount Sinai (Beth Israel)Fellowship, Addiction Psychiatry, 2016 - 2017
Icahn School of Medicine at Mount Sinai (Beth Israel)Chief Residency, Psychiatry, 2015 - 2016
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Psychiatry, 2012 - 2016
New York Medical CollegeClass of 2012
Certifications & Licensure
CT State Medical License 2024 - 2027
NY State Medical License 2013 - 2027
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Addiction Psychiatry
Publications & Presentations
PubMed
- 8 citationsCannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis.Anahita Bassir Nia, Claire L Gibson, Sharron A Spriggs, Samantha E Jankowski, Daniel DeFrancisco
Journal of Psychopharmacology. 2023-05-01 - 19 citationsCannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity.Claire L. Gibson, Anahita Bassir Nia, Sharron Spriggs, Daniel DeFrancisco, Amy Swift
Psychiatry Research. 2020-11-01
Press Mentions
Prescribing Benzodiazepines as-Needed Leads to AbuseDecember 26th, 2016
The AMA Does Not Speak for UsDecember 9th, 2016
Experimental Alzheimer’s Drug Could Reduce Alcohol Withdrawal Damage, Researchers SayMay 26th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









